Oncology & Cancer

Gene test finds which breast cancer patients can skip chemo

Many women with early-stage breast cancer can skip chemotherapy without hurting their odds of beating the disease—good news from a major study that shows the value of a gene-activity test to gauge each patient's risk.

Oncology & Cancer

Potential new colorectal cancer treatment target identified

(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research ...

page 8 from 31